E. James Hutchens, CEO, President, Director

Jim Hutchens is a proven entrepreneur with over 30 years of experience in general and marketing management in the medical technology industry. Mr. Hutchens served as a Managing Partner in Origin Partners, a $55 million early stage, venture capital fund and was the founder and CEO of both Microsurge Inc., a venture-backed, minimally invasive surgery company, and Choice Therapeutics, an advanced wound-care company which was sold to Alliqua Biomedical a NASDAQ list company. Mr. Hutchens also served in senior executive positions at Microvasive Endoscopy, a division of Boston Scientific, Smith & Nephew, and Millipore. He is a former member of the Board of Directors of the Brigham and Womens/ Faulkner Hospital and holds a BS in Business Administration from Boston University.

Robin A. Atlas, M.D.,Director

Dr. Robin Atlas is Medical Director Emerita of Harvard Vanguard Medical Associates, the largest multi-specialty group practice in New England. Dr. Atlas maintained a primary care internal medicine practice at the flagship Kenmore Center for 20 years and served in many executive positions, including Chief of Internal Medicine for the Kenmore Office, Director of Medical Specialties and Deputy Medical Director, in which capacity she created the department of Utilization Management and Clinical Program Development for the Health Centers Division., Dr. Atlas became the Medical Director and Chief Medical Officer for the newly independent Harvard Vanguard Medical Associates and was recognized with the Chief Medical Officer Emerita designation upon her retirement in 2001. Dr. Atlas received her B.S. from the University of Illinois and her M.D. degree from Northwestern University Medical School. She interned and completed an internal medicine residency at Boston’s Beth Israel Hospital.

Ken DaignaultDirector

Ken Daignault has almost 30 years’ experience in the medical device field, with an emphasis in urology. Currently the Director of Gynecology Product Development at HOLOGIC in Massachusetts, Ken has held senior level management positions in major medical device companies, most recently with Boston Scientific as Director of R& D, Urology. He has also held positions at Kendall Healthcare (now Covidien) and CR Bard. Ken has been involved in all aspects of the medical device business, from product development and the design of protocols and procedures for bench and animal pre-clinical testing, to building long-term strategies for multiple-product portfolios at various stages of development.  Ken has strong relationships within the urology field and with key medical institutions, as well as a track record of bringing products from concept through successful product launch.

William Galine, Director

For the past 31 years, Mr. Galine has been involved in corporate finance and marketing. He has worked in public relations and corporate communications since 1984 as a business owner and as a consultant to public companies. Mr. Galine has been involved in helping raise over $40M in financings for multiple publicly traded companies.  His combined experience and knowledge in the area of investor relations and business is an asset to Imagin Medical. He is a graduate of San Diego State University.

Steven Chan, Director

Steven Chan is past Vice President of Cambridge House Conferences, a division of Cambridge House International Inc. He was instrumental in building the company into Canada’s leading investment conference company serving the mining and natural resource industry. At Cambridge House, Mr. Chan worked with all aspects of the mining industry including public companies, brokerage firms, fund managers, analysts and retail investors. Currently, he consults with public companies in the areas of financing and public relations.

Share This